Making sense of chaos in the GLP-1 space.
A reviewer walks through Remedy Meds: $279 first month, a video visit revealed after payment, and a 365-day guarantee he was never eligible for.
Remedy MedsBy Provider Reviews
FDA's September 2026 warning letter has two separate sets of findings. See which one affects patients and which is a legal dispute.
Even at no cost, 10% of new prescriptions go unfilled. See where reducing what patients owe actually changes behavior, and where it does not.
A $95 peptide vial had a brand, a shop and a lab report. See which signals are easy to fake and what a licensed pharmacy is really held to.
Tirzepatide can make the birth control pill less reliable for 4 weeks after each dose change. Semaglutide doesn't. See what your label says.
Inside a Promise Pharmacy compounded tirzepatide shipment: the cold chain, the contents of the vial, the BUD, and how to reach a pharmacist.
Promise PharmacyOne patient shares her real Shed experience: $299 becomes $598, the cancel button is disabled, and a required video visit appears only after you pay.
ShedA new patent covers a fizzy tablet meant to carry GLP-1 medicine past your stomach. See how it would work and how early it really is.
Oral GLP-1s are taking real market share. See the weight loss numbers side by side and where a pill or a shot genuinely fits better.
A study found 15 cases of a rare B1 deficiency brain injury in GLP-1 users. See what the data shows and the warning sign 13 of them had first.
A patient unboxes compounded tirzepatide dispensed by The Pharmacy Hub and compounded by BPI Labs: cooler, gel pack, 4 mL vial, labels, storage card.
The Pharmacy HubThree diagnoses disqualify you from Medicare's $50 GLP-1 price. See why, what a Part D copay really costs, and how cash pay compares.
Most peptides in a wellness stack have zero human trials. See what the research shows, and the 12-year gap five basic habits produced.
SB 1089 passed the California Legislature and awaits the governor. See what it actually does, what it does not do, and what to watch next.
An Australian lab tested 18 vials sold as retatrutide. One matched its label. See what the dosing errors were and why a purity test proves little.
